United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 62,325 | 304,442 | 221,187 | 143,076 | 70,760 |
| Depreciation Amortization | 12,254 | 42,813 | 32,060 | 21,178 | 10,706 |
| Income taxes - deferred | 28,510 | 136,229 | 94,532 | 64,150 | 33,176 |
| Accounts receivable | 15,030 | -23,991 | -19,516 | -8,788 | 63 |
| Accounts payable and accrued liabilities | -3,915 | -22,804 | -7,120 | -38,549 | -38,971 |
| Other Working Capital | -39,765 | -208,192 | -178,122 | -122,075 | -77,088 |
| Other Operating Activity | 23,259 | 95,131 | 75,398 | 65,979 | 38,939 |
| Operating Cash Flow | $97,698 | $323,628 | $218,419 | $124,971 | $37,585 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 14,878 | -51,458 | 91,986 | 37,642 | -5,709 |
| PPE Investments | -4,243 | -111,905 | -90,650 | -83,920 | -40,282 |
| Investing Cash Flow | $10,635 | $-163,363 | $1,336 | $-46,278 | $-45,991 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -999 | N/A | N/A | N/A |
| Common Stock Issued | 5,636 | 16,805 | 9,689 | 3,114 | 1,810 |
| Common Stock Repurchased | -5,904 | -188,000 | -130,925 | -88,000 | 0 |
| Other Financing Activity | 962 | 3,054 | 2,084 | 684 | 318 |
| Financing Cash Flow | $694 | $-169,140 | $-119,152 | $-84,202 | $2,128 |
| Exchange Rate Effect | -931 | 229 | 146 | -154 | 268 |
| Beginning Cash Position | 154,030 | 168,045 | 162,676 | 162,676 | 162,676 |
| End Cash Position | 262,126 | 159,399 | 263,425 | 157,013 | 156,666 |
| Net Cash Flow | $108,096 | $-8,646 | $100,749 | $-5,663 | $-6,010 |
| Free Cash Flow | |||||
| Operating Cash Flow | 97,698 | 323,628 | 218,419 | 124,971 | 37,585 |
| Capital Expenditure | -4,243 | -111,905 | -90,650 | -83,920 | -40,282 |
| Free Cash Flow | 93,455 | 211,723 | 127,769 | 41,051 | -2,697 |